Drreddys Laboratories | RDY - 流动负债

金融业

INR

INR 579.35B

现金及等价物

INR 15.37B

INR 32.13B

INR 301.98B

INR 167.57B

INR 77.34B

股息收益率

INR 0.66

INR 3.05B

INR 8.63B

INR 27.81K

EPS每股收益

INR 0.06

股本和储备

INR 380.46B

INR 43.04B

债务利息支出

INR 1.06B

INR 796M

INR 12.2B

INR 2.14B

INR 2.21B

INR 74.33B

INR 829M

普通股股本

INR 832.69M

19.25

INR 2B

INR 789.05M

销售和管理费用

INR 14.47B

INR 76.53B

贸易债权人

INR 22.36B

应收帐款人

INR 123.17B

	流动负债	更改		日
ANI Pharmaceuticals	USD 239.51M		38.6M	2026-03
Aurora Cannabis	CAD 66.93M		79M	2026-03
Bayer	EUR 33.46B		875M	2026-03
Canopy Growth	CAD 158.44M		60.15M	2026-03
Cipla	INR 70.14B		7.16B	2026-03
Corcept Therapeutics	USD 149.18M		16.9M	2026-03
Drreddys Laboratories	INR 167.57B		165.8B	2026-03
GlaxoSmithKline	GBP 22.43B		1.04B	2026-03
Hikma Pharmaceutical	USD 1.45B		603M	2025-12
Lonza	CHF 3.57B		421M	2025-12
Novartis	USD 31.37B		4.1B	2026-03
Pacira	USD 108.79M		11.8M	2026-03
Phibro Animal Health	USD 281.87M		500K	2026-03
Prestige Brands	USD 120.92M		18.63M	2026-03
Richter Gedeon	HUF 179.31B		8.13B	2026-03
Sun Pharmaceuticals	INR 226.22B		7.93B	2026-03
Supernus Pharmaceuticals	USD 373.93M		35.76M	2026-03
Teva Pharmaceutical Industries	USD 13.53B		76M	2026-03